MRNA vs SAIA · rev $145.0M vs P/E 45, rev $1.76B
Moderna Inc (MRNA) versus Saia Inc (SAIA) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Saia Inc (SAIA) is a trucking company listed on NASDAQ.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
Latest reported SAIA revenue for 2026-06-30 was $1.76B. Net income was $144.1M. SAIA currently screens at market cap $11.33B and trailing P/E 44.8.
MRNA currently screens at market cap $24.52B. SAIA currently screens at market cap $11.33B and trailing P/E 44.8.
Not investment advice. Open the MRNA and SAIA stock pages for the full models.
Not investment advice.